Attainment of low-density lipoprotein cholesterol target in the French general population according to levels of cardiovascular risk: Insights from the MONA LISA study

被引:19
|
作者
Bongard, Vanina [1 ,2 ]
Dallongeville, Jean [3 ]
Arveiler, Dominique [4 ,5 ]
Ruidavets, Jean-Bernard [1 ,2 ]
Amouyel, Philippe [3 ]
Wagner, Aline [4 ]
Ferrieres, Jean [1 ,6 ]
机构
[1] Univ Toulouse 3, INSERM, UMR1027, Dept Epidemiol Econ Sante & Sante Publ, F-31062 Toulouse, France
[2] CHU Toulouse, Serv Epidemiol, Toulouse, France
[3] Univ Lille Nord France, INSERM, U744, Dept Epidemiol & Sante Publ,Inst Pasteur Lille, Lille, France
[4] Univ Strasbourg, Fac Med, EA 3430, Dept Epidemiol & Sante Publ, Strasbourg, France
[5] Hop Univ Strasbourg, Dept Sante Publ, Strasbourg, France
[6] CHU Toulouse, Hop Rangueil, Toulouse, France
关键词
Cardiovascular risk; Dyslipidaemia; Guidelines; LDL-cholesterol; Lipid-lowering therapy; TRENDS; DISEASE; PREVALENCE; FRANCE; EUROPE; ADULTS; LIPIDS;
D O I
10.1016/j.acvd.2012.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. - Controlling low-density lipoprotein (LDL)-cholesterol concentration is of tremendous importance to reduce cardiovascular risk. Aims. - To investigate the attainment of LDL-cholesterol targets recommended in French and European guidelines on cardiovascular prevention, according to levels of cardiovascular risk. Methods. - Participants aged 35 to 74 years (n = 4609) were randomly selected from the general population of three French regions. A standardized data collection was performed to assess cardiovascular risk as described in the French and European guidelines. Results. - Overall, 17.5% of participants were considered to be at high risk and 25.4% at high or very high risk, according to the French and European guidelines, respectively. Only 1.2% of participants with no cardiovascular risk factors according to the French guidelines had an LDL-cholesterol concentration above the recommended target, whereas 82.5% of high-risk subjects did not attain their goal (70.8% among high-risk subjects receiving lipid-lowering therapy). Among untreated people, the median reduction in LDL-cholesterol needed to reach target ranged from 6.6% (lowest-risk groups) to 36.0% (highest-risk subjects). When risk was classified according to the European guidelines, the majority of participants did not reach the recommended LDL-cholesterol targets, irrespective of their level of risk or lipid-lowering therapy. Conclusion. - In a majority of primary prevention candidates with multiple risk factors and in most high-risk subjects, LDL-cholesterol targets recommended by French guidelines are not being achieved, either because of insufficient treatment or because subjects are not recognized as being at risk. More stringent targets proposed by the European guidelines are not being achieved in most cases. (c) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 50 条
  • [1] Statin utilization and low-density lipoprotein cholesterol goal attainment in patients at very high cardiovascular risk: insights from a French general practice population
    Ferrieres, J.
    Steen, D. L.
    Sanchez, R.
    Chin, J.
    Gorcyca, K.
    Khan, I.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 288 - 288
  • [2] Impact of clonal haematopoiesis on atherosclerotic cardiovascular disease according to low-density lipoprotein cholesterol levels in general population
    Lee, Heesun
    Song, Han
    Choi, Su-Yeon
    Koh, Youngil
    Ryu, Gangpyo
    Park, Hyo Eun
    Yoon, Ji Won
    Kim, Min Joo
    Chung, Soie
    Bae, Jung Ho
    Choi, Seung Ho
    Koo, Bon-Kwon
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (09) : 1162 - 1171
  • [3] Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Cardiovascular Risk: Results From a Managed Care Population Study
    Foody, JoAnne
    Khan, Irfan
    Lewis, Barbara
    [J]. CIRCULATION, 2013, 128 (22)
  • [4] ATTAINMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOALS IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK IN THE UNITED KINGDOM: RESULTS FROM A GENERAL PRACTICE POPULATION STUDY
    Ray, K. K.
    Foody, J.
    Khan, I
    Lewis, B. E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A513 - A513
  • [5] Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study
    Freyberg, Josefine
    Landt, Eskild M.
    Afzal, Shoaib
    Nordestgaard, Borge G.
    Dahl, Morten
    [J]. ERJ OPEN RESEARCH, 2023, 9 (02)
  • [6] Achieving target low-density lipoprotein cholesterol levels in the Polish population
    Cybulska, Barbara
    Klosiewicz-Latoszek, Longina
    [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2012, 122 (1-2): : 9 - 11
  • [7] Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol
    Mayr, Manuel
    Gerszten, Robert
    Kiechl, Stefan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (06) : 633 - 635
  • [8] Variability in Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
    Baber, Usman
    Halperin, Jonathan L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) : 1549 - 1551
  • [9] Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population based study
    Jeppesen, J.
    Hansen, T.
    Rasmussen, S.
    Ibsen, H.
    Torp-Pedersen, C.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 445 - 445
  • [10] Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults
    Zhao, Yanglu
    Delaney, Joseph A.
    Quek, Ruben G. W.
    Gardin, Julius M.
    Hirsch, Calvin H.
    Gandra, Shravanthi R.
    Wong, Nathan D.
    [J]. CLINICAL CARDIOLOGY, 2016, 39 (07) : 413 - 420